Capita plc: UK-based international BPO and professional services firm
Civil service pension delays under Capita have prompted a government shift toward insourcing, with auditors reviewing systems and a long-term strategy under way as bereavement and pension payments remain unresolved for thousands.
Capita has warned it could knock £25m-£40m off annual profits for 2026 as delays and backlogs in the Civil Service Pension Scheme persist. The outsourcing group has apologised for the poor service and faces government sanctions while MPs press for accountability as civil servants wait for payments and retirement quotes.
AstraZeneca has announced that Wainua, its gene-silencer drug for transthyretin-mediated amyloid cardiomyopathy, did not meet its primary endpoint in a phase 3 trial. The news triggers a sharp stock drop and prompts investors to rethink the company’s long-term growth targets and the strength of its pipeline.